Followers | 21 |
Posts | 2457 |
Boards Moderated | 1 |
Alias Born | 09/01/2009 |

Monday, November 15, 2010 3:43:20 PM
PRESS RELEASE: Lazard World Dividend & Income Fund Declares Monthly Distribution
NEW YORK--(BUSINESS WIRE)--November 15, 2010--
The Board of Directors of Lazard World Dividend & Income Fund, Inc. (the "Fund") (NYSE:LOR) has authorized the Fund to declare today, pursuant to a level distribution policy, a monthly distribution of $0.07063 per share on the Fund´s outstanding common stock. The distribution is payable on December 23, 2010 to shareholders of record on December 13, 2010. The ex-dividend date is December 9, 2010.
Portfolio data as of October 31, 2010, including performance, asset allocation, top 10 holdings, sector weightings, regional exposure, and other Fund characteristics have been posted on Lazard Asset Management LLC´s ("LAM") website, www.LazardNet.com. Additionally, the notice required by Section 19(a) of the Investment Company Act of 1940, as amended, which provides information regarding the respective estimated amounts of each monthly distribution derived from net investment income, net realized capital gains (short- and long-term) and return of capital, will also be available on www.LazardNet.com.
The Fund´s objective is total return, through a combination of dividends income, and capital appreciation. The Fund´s net assets are invested in a portfolio of approximately 60 to 90 world equity securities, consisting primarily of the highest dividend-yielding stocks selected from the current holdings of other accounts managed by LAM. The equity portfolio is broadly diversified in both developed and emerging market countries and across the capitalization spectrum. The Fund seeks enhanced income by investing in short duration (typically below one year) emerging market forward currency contracts and other emerging market debt instruments.
An indirect subsidiary of Lazard Ltd (NYSE: LAZ), LAM, the Fund´s investment manager, offers a range of equity, fixed-income, and alternative investment products worldwide. As of September 30, 2010, LAM and affiliated asset management companies in the Lazard Group managed approximately $144 billion worth of client assets. For more information about LAM, please go to www.LazardNet.com.
CONTACT: Lazard Ltd
Media:
Judi Mackey,
212-632-1428
judi.mackey@lazard.com
or
Investor:
Ben Wulfsohn,
800-823-6300
ben.wulfsohn@lazard.com
SOURCE: Lazard World Dividend & Income Fund, Inc.
Copyright Business Wire 2010
Click here to go to Dow Jones NewsPlus, a web front page of today´s most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=2zlvsloiAKV80fycieqqWg%3D%3D. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
November 15, 2010 09:36 ET (14:36 GMT)
Recent LAZ News
- Lazard to Announce Second Quarter and First Half 2025 Financial Results • Business Wire • 07/09/2025 12:00:00 PM
- ラザード、クラウス・H・ヘスバーガーがファイナンシャル・スポンサーズ・グループのマネージング・ディレクター兼グローバル共同責任者として加入 • Business Wire • 07/01/2025 11:37:00 AM
- Lazard begrüßt Klaus H. Hessberger als Geschäftsführer und Global Co-Head der Financial Sponsors Group • Business Wire • 07/01/2025 10:00:00 AM
- Lazard accueille Klaus H. Hessberger en tant que directeur général et coresponsable mondial du Financial Sponsors Group • Business Wire • 07/01/2025 10:00:00 AM
- Lazard Welcomes Klaus H. Hessberger as Managing Director and Global Co-Head of Financial Sponsors Group • Business Wire • 07/01/2025 05:50:00 AM
- Lazard Releases 2025 Levelized Cost of Energy+ Report • Business Wire • 06/16/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 09:47:32 PM
- Lazard Reports May 2025 Assets Under Management • Business Wire • 06/10/2025 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 09:50:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 09:50:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 09:50:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 09:50:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 09:49:52 PM
- Lazard eröffnet neuen Hauptsitz in Großbritannien am historischen Manchester Square, W1 • Business Wire • 06/03/2025 10:25:00 AM
- Lazard ouvre son nouveau siège social britannique dans le quartier historique de Manchester Square, W1 • Business Wire • 06/03/2025 10:22:00 AM
- Lazard Asset Management Appoints Eric Van Nostrand Global Head of Markets and Chief Economist • Business Wire • 06/02/2025 01:30:00 PM
- Lazard Opens New UK Headquarters in Historic Manchester Square, W1 • Business Wire • 06/02/2025 06:00:00 AM
- Lazard CEO and Chairman Peter R. Orszag to Speak at the 2025 Morgan Stanley U.S. Financials, Payments & CRE Conference • Business Wire • 05/22/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 09:28:18 PM
- Lazard Asset Management Completes Conversion of Mutual Fund to Launch International Dynamic Equity ETF • Business Wire • 05/12/2025 12:30:00 PM
- Lazard Reports April 2025 Assets Under Management • Business Wire • 05/12/2025 10:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2025 10:15:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2025 10:31:16 AM
- Lazard Reports First-Quarter 2025 Results • Business Wire • 04/25/2025 10:30:00 AM
- Lazard Declares Quarterly Dividend of $0.50 Per Share • Business Wire • 04/24/2025 08:15:00 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM